[MDGL] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
07-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- -31.51%
YoY- -89.66%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -147,541 -76,896 -57,518 -52,546 -36,135 -15,080 -6,364 68.78%
Tax 0 896 69 -160 0 0 0 -
NP -147,541 -77,792 -57,587 -52,546 -36,135 -15,080 -6,364 68.78%
Tax Rate - - - - - - - -
Total Cost 147,541 77,792 57,587 52,546 36,135 15,080 6,364 68.78%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -7.38 -4.28 -3.37 -3.32 -2.34 -0.98 -0.45 59.32%
EPS Diluted -7.38 -4.28 -3.37 -3.32 -2.34 -0.98 -0.45 59.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.